Clinical Trials
CHRISTINE E. LYNN WOMEN’S HEALTH & WELLNESS RESEARCH

Click here to download a printable copy of this information.

BREAST CANCER

DiagnosisInvestigator/SponsorProtocol title & PurposeEligibility
Breast CancerDr. Vijaya Iragavarapu-Charyulu, PhD and Dr. Kathy Schilling, MD

Florida Atlantic University- Sponsored
Semaphorin7A, a novel biomarker of breast cancer may promote growth and metastasis.

We are looking for a potential new tumor marker for breast cancer called Semaphorin 7A. Samples are being collected from women that have been newly diagnosed with breast cancer as well as healthy volunteers. We want to know what role it plays in tumor progression and if it can be a potential target for future treatment.
Women who are 18 years of age or older that have tested positive for breast cancer and have not yet undergone radiation or chemotherapies and plan to have lumpectomy or mastectomy surgery at Boca Raton Regional Hospital.
Breast CancerDr. Kathy Schilling, MD

Collaborative Agreement with European Commission
Virtual Physiological Human: Personalized Predictive Breast Cancer Therapy through Integrated Tissue Micro-Structure Modelling (VPH-PRISM)

Optimal integration of all relevant information including histopathology, radiology, family history, and environment enabling better diagnosis and adequate treatment planning of breast cancer.
Women who are 18 years of age or older that have tested positive for breast cancer and have not yet undergone radiation or chemotherapies.

BREAST IMAGING

Skip Navigation Links.